The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Penningtons Manches LLP

APEX PLAZA, FORBURY ROAD, READING, RG1 1AX, ENGLAND
Tel:
Work 0118 982 2640
Fax:
Fax 0118 982 2641
DX:
117883 READING (APEX PLAZA)
Email:
Web:
www.penningtons.co.uk

Rob Hayes

Tel:
Work 0118 982 2647
Email:
Penningtons Manches LLP

Work Department

Corporate.

Position

Corporate partner specialising in mergers, acquisitions and venture capital work, acting for both institutional investors and high growth companies. Clients include Business Growth Fund; Imperial Innovations LLP, Nexeon Limited and Veryan Medial. Recently acted for Nexeon on a £30 million institutional fundraise; BGF on an equity investment into a software technology company and for the shareholders of a sports clothing business on the sale of the company to Reebok International Limited.

Career

Trained Fennemores; qualified 2000; partner Manches 2008. Previously a graduate trainee and manager for the John Lewis Partnership.

Education

Shrewsbury School; Middlesex University (1992 Linguistics 2:1); Oxford Brookes University (1997 CPE Distinction); Oxford Institute of Legal Practice (1998 LPC Commendation).


London: Corporate and commercial

Venture capital

Within: Venture capital

With offices in London, Reading, Cambridge and Oxford, and leveraging the firm’s IP and life sciences expertise, Penningtons Manches LLP provides ‘no-nonsense and business focused advice’ to an impressive roster of technology corporates, in addition to spin-outs from universities. Justin Starling has a ‘good understanding of how best to move all parties to complete on a transaction’; he recently advised NeRRe Therapeutics on its £23m Series B funding round. Associate Elizabeth Yell has particular expertise advising high-growth technology businesses and is praised for her ‘very efficient advice’. The team also continues to pick up an increased flow of investor-side instructions including, ‘pragmatic deal doerRob Hayes’ recent work for Business Growth Fund. Other clients include Nexeon, Touchstone Innovations, Seedrs, and Evox Therapeutics.

[back to top]

South East: Corporate and commercial

Corporate and commercial: Thames Valley, Berks, Oxon, M4/M40

Within: Corporate and commercial: Thames Valley, Berks, Oxon, M4/M40

Penningtons Manches LLP’s recent workload includes high-profile venture capital and spin-out transactions. Technology and life sciences expert Will Axtell assisted Evox Therapeutics and Vaccitech with their spin-outs from the University of Oxford, which included advising on establishing the companies and handling a £10m investment in each from Oxford Sciences Innovation. Other work highlights saw David Tighe assist with Evotec’s £55.7m acquisition of Cyprotex and Justin Starling advise King’s College London on an investment from Abingworth in GammaDelta Therapeutics, an immunotherapy company founded on research from the university along with that of Cancer Research Technology and The Francis Crick Institute. Chris Shelley, who heads the commercial practice outside London, ‘provides excellent input’ and recently advised on a range of niche commercial contracts for the firm’s new client WideCells Group, which included agreements with cord blood banks for the provision of stem cell processing and storage. Quarto Publishing Group, Natural Environment Research Council and Nexeon are additional clients. Rob Hayesprovides excellent and timely advice’ and recently promoted partner James Wentunderstands the practical implications of transactions’. Commercial partner Joanne Vengadesan splits her time between Basingstoke and Reading and is noted with Nicola McConville, who joined from Blake Morgan LLP. The corporate practice is headed nationally by Guildford-based Simon Bickerdike.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to